Claudin-Low Breast Cancer; Clinical & Pathological Characteristics
about
Fatty acid synthase expression and its association with clinico-histopathological features in triple-negative breast cancer.The crossroads of breast cancer progression: insights into the modulation of major signaling pathways.Racial disparity in breast cancer: can it be mattered for prognosis and therapy.Foe or friend? Janus-faces of the neurovascular unit in the formation of brain metastases.Prognostic Significance of Low Claudin3 Expression in Luminal Breast Cancers.
P2860
Claudin-Low Breast Cancer; Clinical & Pathological Characteristics
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Claudin-Low Breast Cancer; Clinical & Pathological Characteristics
@ast
Claudin-Low Breast Cancer; Clinical & Pathological Characteristics
@en
type
label
Claudin-Low Breast Cancer; Clinical & Pathological Characteristics
@ast
Claudin-Low Breast Cancer; Clinical & Pathological Characteristics
@en
prefLabel
Claudin-Low Breast Cancer; Clinical & Pathological Characteristics
@ast
Claudin-Low Breast Cancer; Clinical & Pathological Characteristics
@en
P2093
P2860
P1433
P1476
Claudin-Low Breast Cancer; Clinical & Pathological Characteristics
@en
P2093
Anita L Bane
Anna Dvorkin-Gheva
Gregory R Pond
John Hassell
Mark Levine
Robin M Hallett
Tim Whelan
P2860
P304
P356
10.1371/JOURNAL.PONE.0168669
P407
P577
2017-01-03T00:00:00Z